AnalystsJason ButlerJason Butler's Stock Forecasts
AnalystsJason Butler
Sectors:
Analyst Ranking
Bottom 17%
#3527 out of 4227 analysts
Average Return
-1.55%
Win Rate
39%26 out of 67
Risk vs Reward
Poor
Good
Jason Butler's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Prothena Corp Public Ltd CoPRTA | +170.41% | $25.75 | $69.63 | 2022-05-24 - 2023-05-24 | Buy |
Gamida Cell LtdGMDA | +156.88% | $0.76 | $1.96 | 2023-03-27 - 2023-05-26 | Buy |
Acadia Pharmaceuticals IncACAD | +114.74% | $13.91 | $29.87 | 2018-08-08 - 2019-08-09 | Buy |
Karuna Therapeutics IncKRTX | +82.49% | $120.65 | $220.17 | 2022-06-27 - 2023-05-26 | Buy |
Marinus Pharmaceuticals IncMRNS | +74.84% | $32.12 | $56.16 | 2014-08-25 - 2015-08-26 | Buy |
Jason Butler Analyst Color
Get additional color on Jason Butler's coverage of popular stocks
Jason Butler's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Cytokinetics IncCYTK | 6 | Buy | $71.00 | +90.04% | Reiterates | 6 days ago |
Gamida Cell LtdGMDA | 8 | Buy | $6.00 | +206.12% | Maintains | 10 days ago |
Cormedix IncCRMD | 4 | Buy | $19.00 | +288.55% | Maintains | 10 days ago |
Trevena IncTRVN | 2 | Buy | $2.00 | +73.91% | Reiterates | 11 days ago |
Gh Research PLCGHRS | 2 | Buy | $49.00 | +345.45% | Maintains | 17 days ago |
Precigen IncPGEN | 3 | Buy | $14.00 | +1,047.54% | Reiterates | 17 days ago |
Syros Pharmaceuticals IncSYRS | 2 | Buy | $15.00 | +305.41% | Maintains | 18 days ago |
Halozyme Therapeutics IncHALO | 5 | Buy | $66.00 | +98.80% | Reiterates | 18 days ago |
Viridian Therapeutics IncVRDN | 3 | Buy | $44.00 | +85.42% | Maintains | 19 days ago |
Acadia Pharmaceuticals IncACAD | 6 | Buy | $23.00 | -7.18% | Maintains | 20 days ago |
Prothena Corp Public Ltd CoPRTA | 2 | Buy | $82.00 | +23.42% | Reiterates | 23 days ago |
Argenx SeARGX | 2 | Buy | $445.00 | +10.71% | Maintains | 23 days ago |
Athira Pharma IncATHA | 2 | Buy | $20.00 | +660.46% | Reiterates | 2 months ago |
Karuna Therapeutics IncKRTX | 4 | Buy | $323.00 | +46.70% | Reiterates | 2 months ago |
Rezolute IncRZLT | 2 | Buy | $8.00 | +280.95% | Reiterates | 3 months ago |
Morphosys AgMOR | 1 | Buy | $15.00 | +137.34% | Maintains | 6 months ago |
Minerva Neurosciences IncNERV | 1 | Hold | N/A | N/A | Downgrades | 7 months ago |
Plx Pharma IncPLXPQ | 1 | Hold | N/A | N/A | Downgrades | 9 months ago |
Applied Molecular Transport IncAMTI | 2 | Buy | $50.00 | N/A | Maintains | a year ago |
Marinus Pharmaceuticals IncMRNS | 2 | Buy | $22.00 | N/A | Maintains | a year ago |
Quince Therapeutics IncQNCX | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Quoin Pharmaceuticals LtdQNRX | 1 | Buy | $100.00 | N/A | Initiates Coverage On | a year ago |
Arena Pharmaceuticals IncARNA | 1 | Hold | N/A | N/A | Downgrades | a year ago |
Enanta Pharmaceuticals IncENTA | 4 | Buy | $116.00 | N/A | Maintains | 2 years ago |
Hookipa Pharma IncHOOK | 1 | Buy | $11.00 | N/A | Maintains | 2 years ago |
Arbutus Biopharma CorpABUS | 1 | Buy | $9.00 | N/A | Maintains | 2 years ago |
Adamas Pharmaceuticals IncADMS | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Esperion Therapeutics IncESPR | 1 | Buy | $111.00 | N/A | Maintains | 2 years ago |
Ovid Therapeutics IncOVID | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Pfenex IncPFNX | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Zogenix IncZGNX | 1 | Buy | $56.00 | N/A | Initiates Coverage On | 6 years ago |
Intra Cellular Therapies IncITCI | 1 | Buy | N/A | N/A | Upgrades | 6 years ago |
Forward Pharma AFWPAY | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.